Introduction
This report describes the activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria, extending a previous study comparing the activity of HMR 3004 against these organisms.
1 All bacteria tested in this study were randomly selected recent clinical isolates from the Wadsworth Anaerobic Bacteriology Laboratory, VA Greater Los Angeles Healthcare System in West Los Angeles. Bacteria were identified according to established procedures. 2 MICs were determined by the NCCLS-approved Wadsworth agar dilution technique using an inoculum of 10 5 cfu/spot, and Brucella base-laked blood agar. 3 Plates were incubated in an anaerobic chamber (Anaerobe Systems, San Jose, CA, USA) for 48 h at 37°C. MICs were defined as the lowest concentration of antimicrobial resulting in a marked change in the appearance of growth as compared with the control plate, as described in the NCCLS protocol. Reference strains of Bacteroides fragilis (ATCC 25285) and Bacteroides thetaiotaomicron (ATCC 29741) were used as controls in each test. Telithromycin was obtained from Hoechst-Marion-Roussel R&D (Romainville, France).
Results of this study are listed in Table I . For the comparative values of the agents tested the reader is referred to a previously published report. 1 4 only one of 13 strains had an MIC of 8 mg/L (this strain was also resistant to the other macrolides tested previously). Bilophila wadsworthia was the third most common anaerobe isolated in cases of perforated or gangrenous appendicitis. 5 Telithromycin had good activity against B. wadsworthia (85% inhibited at 4 mg/L) in contrast to the other macrolides reported previously, except for HMR 3004, which had similar activity to telithromycin. The other macrolides inhibited 4-33% of strains of B. wadsworthia. Clostridium ramosum strains at 2 mg/L. Telithromycin was very active against Peptostreptococcus spp., inhibiting all strains at 2 mg/L; azithromycin, clarithromycin, erythromycin and roxithromycin, tested previously, were active against 66-83% of strains at 4 mg/L. 1 Telithromycin inhibited approximately 90% of non-spore-forming Grampositive bacilli at 2 mg/L. The macrolides tested previously had very similar activity against these strains.
It should be noted that testing methods, especially the inclusion of CO 2 in the atmosphere, can variably affect the activity of some macrolides because of a pH effect. 7 Goldstein et al. 8 tested telithromycin and other ketolide and macrolide compounds against organisms involved in bite wound infections by the standard NCCLS approved agar 468 dilution method (as was done in this study). They found that telithromycin was active against Bacteroides tectus, Bacteroides forsythus, Peptostreptococcus, Prevotella and Porphyromonas spp. Five of 20 strains of Fusobacterium were resistant. 8 In our study, telithromycin was also active against Porphyromonas, Prevotella (98%) and Peptostreptococcus spp. Ednie et al. 9 tested 352 strains of anaerobes using Oxyrase and aerobic incubation for those strains not requiring CO 2 and pH adjustment to a final pH of 7.1-7.2 and anaerobic incubation for those strains requiring CO 2 . The MIC ranges (approximately 0.5-Ͼ64 mg/L) for the B. fragilis group were similar to those seen in our study (2-Ͼ64 mg/L) as was the MIC 90 (Ͼ64 mg/L), although the MIC 50 (8 mg/L) was lower than ours (32 mg/L). Overall MIC 50 s and MIC 90 s were lower than found in this study. Edlund and co-workers 10 In summary, telithromycin showed good activity against certain groups of anaerobes. Further study into the clinical utility of this agent for specific infections involving certain anaerobes merits investigation.
